The best of London for free. Sign up for our email to enjoy London without spending a thing (as well as some options when you’re feeling flush). Our newsletter hand-delivers the best bits to ...

Thanks for subscribing! Look out for your first newsletter in your inbox soon! The best of London for free. Sign up for our email to enjoy London without spending a thing (as well as some options ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Alia Shoaib is a freelance news reporter for Newsweek based between London, UK and Abuja ... Americans struggling with depression. The nasal spray Spravato, which is made from the drug esketamine ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...